Published in Clin Infect Dis on September 01, 1993
Human microsporidial infections. Clin Microbiol Rev (1994) 4.66
Waterborne protozoan pathogens. Clin Microbiol Rev (1997) 2.88
Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia. Clin Microbiol Rev (1999) 1.50
Detection of microsporidial spores in fecal specimens from patients diagnosed with cryptosporidiosis. J Clin Microbiol (1994) 1.12
Identification and characterization of microsporidia from fecal samples of HIV-positive patients from Lagos, Nigeria. PLoS One (2012) 0.92
A new acid-fast trichrome stain for simultaneous detection of Cryptosporidium parvum and microsporidial species in stool specimens. J Clin Microbiol (1997) 0.81
Disseminated Encephalitozoon (Septata) intestinalis infection in a patient with AIDS: novel diagnostic approaches and autopsy-confirmed parasitological cure following treatment with albendazole. J Clin Microbiol (1995) 0.80
Triple protozoal enteropathy of the small intestine in an immunocompromised male: A rare histopathology report. Indian J Sex Transm Dis (2013) 0.77
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
A method to identify protein sequences that fold into a known three-dimensional structure. Science (1991) 14.08
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A (1996) 12.92
Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J (1999) 10.82
Profile analysis. Methods Enzymol (1990) 9.40
Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A (1992) 9.19
VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol (1997) 6.71
Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae. Mol Cell Biol (1987) 5.84
Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A (1999) 4.84
Human microsporidial infections. Clin Microbiol Rev (1994) 4.66
Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med (1985) 2.95
Bacteriophage P1 cre gene and its regulatory region. Evidence for multiple promoters and for regulation by DNA methylation. J Mol Biol (1986) 2.80
Genomic targeting with purified Cre recombinase. Nucleic Acids Res (1993) 2.74
Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells. Proc Natl Acad Sci U S A (1992) 2.72
Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology (2005) 2.69
Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine. Antimicrob Agents Chemother (1985) 2.55
Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime. Antimicrob Agents Chemother (1981) 2.48
The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics. Soz Praventivmed (1994) 2.38
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
Human pharmacology of cefotaxime (HR 756), a new cephalosporin. Antimicrob Agents Chemother (1979) 2.29
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin. Antimicrob Agents Chemother (1985) 2.25
Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem (1998) 2.24
Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev (1997) 2.21
A positive selection vector for cloning high molecular weight DNA by the bacteriophage P1 system: improved cloning efficacy. Proc Natl Acad Sci U S A (1992) 2.20
Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection. N Engl J Med (1997) 2.05
Spread of HIV-1 to children in Cambodia. Lancet (1997) 1.95
Disseminated cat-scratch disease: detection of Rochalimaea henselae in affected tissue. Eur J Pediatr (1994) 1.92
Co-infection with human immunodeficiency virus-type 1 (HIV-1) and cytomegalovirus in two intravenous drug users. Ann Intern Med (1989) 1.82
Microsporidial infections in immunodeficient and immunocompetent patients. Clin Infect Dis (1994) 1.81
Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol (1998) 1.81
A bacterial mutation blocking P2 phage late gene expression. Proc Natl Acad Sci U S A (1975) 1.79
Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS). Acta Neuropathol (1985) 1.76
Quantitative detection of Streptococcus pneumoniae in nasopharyngeal secretions by real-time PCR. J Clin Microbiol (2001) 1.75
Disruption of the c/ebp alpha gene in adult mouse liver. Mol Cell Biol (1997) 1.72
Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis (1998) 1.69
Site-directed recombination in the genome of transgenic tobacco. Mol Gen Genet (1990) 1.60
Highly sensitive methods for quantitation of human immunodeficiency virus type 1 RNA from plasma, cells, and tissues. J Clin Microbiol (1999) 1.53
Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol Endocrinol (1998) 1.52
Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS (1997) 1.50
Tickborne encephalitis despite specific immunoglobulin prophylaxis. Lancet (1995) 1.49
Genetic analysis of bacteriophage P4 using P4-plasmid ColE1 hybrids. Mol Gen Genet (1980) 1.48
Rash with amoxycillin-clavulanate therapy in HIV-infected patients. Lancet (1989) 1.47
Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR. J Microbiol Methods (2000) 1.43
Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. J Infect Dis (2000) 1.41
Diagnostic value of cerebrospinal fluid examination in children with peripheral facial palsy and suspected Lyme borreliosis. Neurology (1997) 1.40
[New developments and prospects of antiviral chemotherapy]. Internist (Berl) (1992) 1.39
[A puzzling circulatory failure after total hip replacement]. Ann Fr Anesth Reanim (2003) 1.39
GFPcre fusion vectors with enhanced expression. Anal Biochem (1999) 1.39
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis (2016) 1.39
Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood (1993) 1.35
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med (1997) 1.35
Segmental genomic replacement by Cre-mediated recombination: genotoxic stress activation of the p53 promoter in single-copy transformants. Nucleic Acids Res (1997) 1.32
Segmental genomic replacement in embryonic stem cells by double lox targeting. Nucleic Acids Res (1999) 1.31
Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1. Eur J Immunol (1997) 1.31
Brief expression of a GFP cre fusion gene in embryonic stem cells allows rapid retrieval of site-specific genomic deletions. Nucleic Acids Res (1997) 1.30
A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome. J Virol (1992) 1.29
DNA polymerase alpha from Drosophila melanogaster embryos. Subunit structure. J Biol Chem (1980) 1.29
Conditional gene knockout using Cre recombinase. Mol Biotechnol (2001) 1.28
A mouse genomic library in the bacteriophage P1 cloning system: organization and characterization. Mamm Genome (1992) 1.25
A method for the quantification of intracellular zidovudine nucleotides. J Infect Dis (1991) 1.24
Conditional gene knockout using cre recombinase. Methods Mol Biol (2000) 1.23
Extrapulmonary and disseminated infections due to Mycobacterium malmoense: case report and review. Clin Infect Dis (1993) 1.21
Side-effects due to the intravenous infusion of erythromycin lactobionate. Infection (1983) 1.19
Biological variability of multiple dose pharmacokinetics of netilmicin in man. Eur J Clin Pharmacol (1983) 1.19
Nuclear targeting determinants of the phage P1 cre DNA recombinase. Nucleic Acids Res (1999) 1.18
Broad range polymerase chain reaction for diagnosis of rat-bite fever caused by Streptobacillus moniliformis. Pediatr Infect Dis J (2001) 1.18
Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring. Arch Dis Child (2001) 1.17
Mutants of satellite bacteriophage P4 that are defective in the suppression of transcriptional polarity. J Mol Biol (1981) 1.16
Detection of Septata intestinalis in stool specimens and coprodiagnostic monitoring of successful treatment with albendazole. Clin Infect Dis (1994) 1.16
Stoichiometry of the Cre recombinase bound to the lox recombining site. Nucleic Acids Res (1992) 1.13
Pulmonary and intestinal microsporidiosis in a patient with the acquired immunodeficiency syndrome. Am Rev Respir Dis (1992) 1.13
Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10. J Exp Med (1993) 1.12
Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. Antimicrob Agents Chemother (1987) 1.11
Immunological comparison of purified DNA polymerase alpha from embryos of Drosophila melanogaster with forms of the enzyme present in vivo. J Biol Chem (1982) 1.07
Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. Int J Antimicrob Agents (2000) 1.07
Thalidomide treatment of mucosal ulcerations in HIV infection. Arch Dis Child (1996) 1.06
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol (1998) 1.05
Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br J Dermatol (2004) 1.04
Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol (1991) 1.04
Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection. Am J Pathol (2000) 1.03
Brain growth in man. Bibl Anat (1986) 1.03
Disseminated microsporidiosis due to Encephalitozoon hellem: pulmonary colonization, microhematuria, and mild conjunctivitis in a patient with AIDS. Clin Infect Dis (1993) 1.03
Disseminated coinfection with Mycobacterium avium complex and Mycobacterium kansasii in a patient with AIDS and liver abscess. Clin Infect Dis (1992) 1.02
Escherichia coli rpoC397 encodes a temperature-sensitive C-terminal frameshift in the beta' subunit of RNA polymerase that blocks growth of bacteriophage P2. J Bacteriol (1996) 1.02
Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol (2001) 1.01
Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis. Arch Dis Child (2004) 1.01
Generation of Cre recombinase-specific monoclonal antibodies, able to characterize the pattern of Cre expression in cre-transgenic mouse strains. J Immunol Methods (1997) 1.01
Brucellosis: an occupational hazard for medical laboratory personnel. Report of five cases. Infection (1994) 1.01
Determination of transport kinetics of chick MCT3 monocarboxylate transporter from retinal pigment epithelium by expression in genetically modified yeast. Biochemistry (2000) 1.01
Evaluation of commercial slides for detection of immunoglobulin G against Bartonella henselae by indirect immunofluorescence. Eur J Clin Microbiol Infect Dis (1997) 1.01
Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters. Antimicrob Agents Chemother (1991) 1.01
Shortcomings of chest radiography in detecting Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr (1994) 1.00